Acknowledgement
Supported by : Iran University of Medical Sciences
References
- Andreyev HJ, Norman AR, Cunningham D, et al (2001). Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer, 85, 692-6. https://doi.org/10.1054/bjoc.2001.1964
- Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA (1998). Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. J Natl Cancer Inst, 90, 675-84. https://doi.org/10.1093/jnci/90.9.675
- Allegra CJ, Jessup JM, Somerfield MR, et al (2009). American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol, 27, 2091-6. https://doi.org/10.1200/JCO.2009.21.9170
- Borras E, Jurado I, Hernan I, et al (2011). Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing. BMC Cancer, 11, 406. https://doi.org/10.1186/1471-2407-11-406
- Boyd EM, Bench AJ, van 't Veer MB, et al (2011). High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies. Br J Haematol, 155, 609-12. https://doi.org/10.1111/j.1365-2141.2011.08868.x
- Chateigner-Boutin AL, Small I (2007). A rapid high-throughput method for the detection and quantification of RNA editing based on high-resolution melting of amplicons. Nucleic Acids Res, 35, e114. https://doi.org/10.1093/nar/gkm640
- Chen D, Wang YY, Chuai ZR, et al (2014). High-resolution melting analysis for accurate detection of BRAF mutations: a systematic review and meta-analysis. Sci Rep, 4, 4168.
- De Roock W, De Vriendt V, Normanno N, Ciardiello F, Tejpar S (2011). KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol, 12, 594-603. https://doi.org/10.1016/S1470-2045(10)70209-6
- Di Nicolantonio F, Martini M, Molinari F, et al (2008). Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol, 26, 5705-12. https://doi.org/10.1200/JCO.2008.18.0786
- Fransen K, Klintenas M, Osterstrom A, et al (2004). Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis, 25, 527-33.
- Guedes JG, Veiga I, Rocha P, et al (2013). High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer. BMC Cancer, 13, 169. https://doi.org/10.1186/1471-2407-13-169
- Janakiraman M, Vakiani E, Zeng Z, et al (2010). Genomic and biological characterization of exon 4 KRAS mutations in human cancer. Cancer Res, 70, 5901-11. https://doi.org/10.1158/0008-5472.CAN-10-0192
- Ji H, Wang Z, Perera SA, et al (2007). Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. Cancer Res, 67, 4933-9. https://doi.org/10.1158/0008-5472.CAN-06-4592
- Katsanis SH, Katsanis N (2013). Molecular genetic testing and the future of clinical genomics. Nat Rev Genet, 14, 415-26.
- Koochak A, Rakhshani N, Karbalaie Niya MH, et al (2016). Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran. Asian Pac J Cancer Prev, 17, 603-8. https://doi.org/10.7314/APJCP.2016.17.2.603
- Krypuy M, Newnham GM, Thomas DM, Conron M, Dobrovic A (2006). High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer, 6, 295. https://doi.org/10.1186/1471-2407-6-295
- Li BS, Wang XY, Xu AG, et al (2012). High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms. Clin Colorectal Cancer, 11, 280-90. https://doi.org/10.1016/j.clcc.2012.04.001
- Mader E, Lukas B, Novak J (2008). A strategy to setup codominant microsatellite analysis for high-resolutionmelting- curve-analysis (HRM). BMC Genet, 9, 69.
- Minoo P, Moyer MP, Jass JR (2007). Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol, 212, 124-33. https://doi.org/10.1002/path.2160
- Montgomery JL, Sanford LN, Wittwer CT (2010). Highresolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn, 10, 219-40. https://doi.org/10.1586/erm.09.84
- Morandi L, de Biase D, Visani M, et al (2012). Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation. PloS One, 7, e36084. https://doi.org/10.1371/journal.pone.0036084
- Negru S, Papadopoulou E, Apessos A, et al (2014). KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study. BMJ, 4, e004652.
- Packham D, Ward RL, Ap Lin V, Hawkins NJ, Hitchins MP (2009). Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers. Diagn Mol Pathol, 18, 62-71. https://doi.org/10.1097/PDM.0b013e318182af52
- Pinto P, Rocha P, Veiga I, et al (2011). Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer. Cancer Genet, 204, 439-46. https://doi.org/10.1016/j.cancergen.2011.07.003
- Popovici V, Budinska E, Tejpar S, et al (2012). Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J Clin Oncol, 30, 1288-95. https://doi.org/10.1200/JCO.2011.39.5814
- Reed GH,Wittwer CT (2004). Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem, 50, 1748-54. https://doi.org/10.1373/clinchem.2003.029751
- Roth AD, Tejpar S, Delorenzi M, et al (2010). Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol, 28, 466-74. https://doi.org/10.1200/JCO.2009.23.3452
- Simi L, Pratesi N, Vignoli M, et al (2008). High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. Am J Clin Pathol, 130, 247-53. https://doi.org/10.1309/LWDY1AXHXUULNVHQ
- Sundstrom M, Edlund K, Lindell M, et al (2004). KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice. BMC Cancer, 10, 660.
- Takano T, Ohe Y, Tsuta K, et al (2007). Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Clin Cancer Res, 13, 5385-90. https://doi.org/10.1158/1078-0432.CCR-07-0627
- Tan YH, Liu Y, Eu KW, et al (2008). Detection of BRAF V600E mutation by pyrosequencing. Pathology, 40, 295-8. https://doi.org/10.1080/00313020801911512
- Taylor CF (2009). Mutation scanning using high-resolution melting. Biochem Soc Trans, 37, 433-7. https://doi.org/10.1042/BST0370433
- Wittwer CT (2009). High-resolution DNA melting analysis: advancements and limitations. Hum Mutat, 30, 857-9. https://doi.org/10.1002/humu.20951
- Wooster R, Futreal AP, Stratton MR (2006). Sequencing analysis of BRAF mutations in human cancers. Methods Enzymol, 407, 218-24.
- Vakil L, Najafipour R, Rakhshani N, et al (2016). Investigation of FIH-1 and SOCS3 expression in KRAS mutant and wild-type patients with colorectal cancer. Tumour Biol, 37, 8841-8. https://doi.org/10.1007/s13277-015-4723-1